HCV (Hepatitis C Virus) Viral and Host Genotyping (IL28B, Interleukin 28B) in China
HCV (Hepatitis C Virus) Viral and Host Genotyping (IL28B, Interleukin 28B) in China
The primary objective of this study is to estimate the distributions of HCV viral/human
 genotypes (including IL28B and inosine triphosphatase, ITPA), and HCV RNA level among ITPA
 gene among 1000 Han ethnic Chinese patients with HCV who are antiviral treatment naive at the
 time the study is conducted.
A sample of 1000 Han ethnic Chinese male or female who are ≥ 18 years old with a recent
 confirmation of anti-HCV-antibody positive and HCV RNA positive but antiviral treatment naive
 from 28 university affiliated hospital in China. The primary objective of this study is to
 estimate the distributions of HCV Viral genotyping(ie, genotype 1 through 6 and their known
 subtypes), and host genotypes, both inosine triphosphatase (ITPA) gene, and IL28B. This study
 also collects other data including patients' demographic and clinical characteristics. There
 is no active antiviral treatments and no follow-up in this study.
Inclusion Criteria:

 -  male or female

 -  Han ethnic

 -  ≥ 18 years old

 -  recent confirmation of anti-HCV-antibody positive and HCV RNA positive 30 days prior
 to the recruitment

 -  antiviral or interferon treatment naive

 Exclusion Criteria:

 -  < 18 years old

 -  not Han ethnic

 -  treated by antiviral before this study